Hypertrophic Cardiomyopathy as a Key Feature of MRAS‐Related Noonan Syndrome: New Case and Comprehensive Literature Review
Prenatal Diagnosis · 2026-04 · 46 (4) · 581-588
DOI: 10.1002/pd.70134 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Prenatal Diagnosis, online erschienen am 22.03.2026. Verfasst von Romain Martineau und 10 weiteren Autor:innen. Beteiligte Einrichtung: Resident in Gynecology, Obstetrics and Fetopathology, Montpellier University, Montpellier, France. Hauptthemen laut MEDLINE: Noonan Syndrome, Cardiomyopathy, Hypertrophic. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Noonan syndrome (NS) is a rare multisystemic condition among the RASopathy group, characterized by a broad phenotypic spectrum and genetic variability. It results from pathogenic variants in genes regulating the RAS/MAPK pathway, affecting cell proliferation and differentiation. While the PTPN11 gene accounts for approximately 50% of cases, other genes, including MRAS , have been implicated. NS presents with features such as facial dysmorphism, short stature, and cardiac anomalies. Hypertrophic cardiomyopathy (HCM) is a major contributor to mortality, with specific variants conferring higher risk. This article includes a review of the literature on NS with pathogenic MRAS variants and describes an eighth case, the first documented with early and severe antenatal manifestations. The fetus exhibited increased nuchal translucency, agenesis of the ductus venosus, pulmonary lymphangiectasia, and complex hepatic vascular anomalies. A cesarean section was performed at 33 weeks' gestation due to worsening fetal pleural effusions and maternal intolerance to polyhydramnios. Despite intensive postnatal care, the newborn died from refractory shock and multi‐organ failure. Histopathology revealed HCM, obliterative portal venopathy and lymphangiectasia, consistent with NS pathology. These findings suggest that pathogenic MRAS variants confer a high risk of severe HCM (100% of cases). Moreover, emerging targeted therapies, such as MEK inhibitors, offer potential for treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Resident in Gynecology, Obstetrics and Fetopathology, Montpellier University, Montpellier, France.
- Medical Genetics Department, University Hospital of Montpellier, Montpellier University, Montpellier, France.
- Department of Obstetrics and Gynecology, University Hospital of Montpellier, Montpellier University, Montpellier, France.
- Inserm, CESP Center for Research in Epidemiology and Population Health, Reproduction and Child Development, Villejuif, France.
- DESBREST Institute of Epidemiology and Public Health (IDESP), University of Montpellier, INSERM, Montpellier, France.
- Department of Pathology, Hospices Civils de Lyon & Université Claude Bernard Lyon 1, Lyon, France.
ORCID-Profile: Romain Martineau, Sophie Collardeau-Frachon, Valentin Ruault, Sophie Colomb, Marjolaine Willems
Zitieren
APA
Martineau, R., Wells, C., Fuchs, F., Collardeau-Frachon, S., Ruault, V., Colomb, S., Faure, J. M., Bartholmot, C., Vincenti, M., Ganne, B., & Willems, M. (2026). Hypertrophic Cardiomyopathy as a Key Feature of MRAS‐Related Noonan Syndrome: New Case and Comprehensive Literature Review. Prenatal Diagnosis, 46(4), 581-588. https://doi.org/10.1002/pd.70134
Vancouver
Martineau R, Wells C, Fuchs F, Collardeau-Frachon S, Ruault V, Colomb S, et al. Hypertrophic Cardiomyopathy as a Key Feature of MRAS‐Related Noonan Syndrome: New Case and Comprehensive Literature Review. Prenatal Diagnosis. 2026;46(4):581-588. doi:10.1002/pd.70134
BibTeX
@article{Martineau2026,
author = {Martineau, Romain and Wells, Constance and Fuchs, Florent and Collardeau-Frachon, Sophie and Ruault, Valentin and Colomb, Sophie and Faure, Jean-Michel and Bartholmot, Caroline and Vincenti, Marie and Ganne, Benjamin and Willems, Marjolaine},
title = {Hypertrophic Cardiomyopathy as a Key Feature of MRAS‐Related Noonan Syndrome: New Case and Comprehensive Literature Review},
journal = {Prenatal Diagnosis},
year = {2026},
volume = {46},
number = {4},
pages = {581--588},
doi = {10.1002/pd.70134}
}
EUVIMED